Denali Therapeutics Q1 2026 Earnings Narrower Loss Surprises Stock Edges Higher Biomerica Q1 2026 Earnings Net Loss of 044 Per Share Amid Lack of Revenue Disclosure LTH Q1 2026 Earnings EPS Surprise Drives Qualified Optimism Despite Weak Stock Reaction Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Crexendo CXDO Q1 2026 Earnings Strong EPS Beat Despite Modest Market Response EQBK Q1 2026 Earnings EPS Misses Estimates Yet Stock Shows Resilience